This review highlights the advancements in neuro-oncological imaging, emphasizing the importance of advanced imaging tools in diagnosing, staging, and monitoring treatment responses for central nervous system (CNS) tumors. Key imaging modalities discussed include PET tracers and radiolabeled amino acids, PET/MRI, radiomics, deep learning, MR perfusion imaging, MR fingerprinting, MR spectroscopy imaging, MR elastography, and intra-operative ultrasound techniques. Each modality is evaluated for its accuracy and effectiveness in various aspects of neuro-oncology, such as distinguishing between malignant and benign tumors, assessing cancer staging, predicting prognosis, and evaluating post-treatment outcomes. The review also addresses the challenges and limitations of these imaging techniques, including the need for further research to enhance their clinical utility. Overall, the advancements in neuro-oncological imaging are expected to improve the management of brain tumors, leading to better patient outcomes.This review highlights the advancements in neuro-oncological imaging, emphasizing the importance of advanced imaging tools in diagnosing, staging, and monitoring treatment responses for central nervous system (CNS) tumors. Key imaging modalities discussed include PET tracers and radiolabeled amino acids, PET/MRI, radiomics, deep learning, MR perfusion imaging, MR fingerprinting, MR spectroscopy imaging, MR elastography, and intra-operative ultrasound techniques. Each modality is evaluated for its accuracy and effectiveness in various aspects of neuro-oncology, such as distinguishing between malignant and benign tumors, assessing cancer staging, predicting prognosis, and evaluating post-treatment outcomes. The review also addresses the challenges and limitations of these imaging techniques, including the need for further research to enhance their clinical utility. Overall, the advancements in neuro-oncological imaging are expected to improve the management of brain tumors, leading to better patient outcomes.